Reproductive disorders
Conditions
Interventions
Petinotherapy group:NA
G-CSF/ petinotherapy group (short-acting G-CSF followed by petinotherapy),:NA
Short-acting G-CSF group:NA
control group (patients receiving only basal medication and/or other prophylactic or therapeutic regiments, but not receiving any G-CSF):NA
Sponsors
The Second Hospital of Lanzhou University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1.Patients aged between 18 and 45 years (inclusive of 18 and 45 years); 2.Patients with recurrent miscarriage and/or previous implantation failure; 3.The administration route for Tuopei Filgrastim Injection and other G-CSF agents is subcutaneous injection.
Exclusion criteria
Exclusion criteria: 1. Severe hepatic, renal, cardiac, or pulmonary dysfunction; 2. Pregnant women with a history of severe diseases or severe mental disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Continuous clinical pregnancy rate at 12 weeks gestation;Continuous clinical pregnancy rate at 24 weeks gestation;Spontaneous early abortion rate; | — |
Countries
China
Contacts
Public ContactFang Wang
The Second Hospital of Lanzhou University
Outcome results
None listed